ArticleScientific reports2026
HPLC-DAD analysis of functional dietary supplements followed by liquid-liquid microextraction-assisted FTIR identification of IR-active ingredients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate identification of active ingredients in dietary supplements and functional beverages is essential for ensuring product quality and consumer safety. Fourier transform infrared (FTIR) spectrometry, when coupled with high performance liquid chromatography (HPLC), provides molecular information for compound characterization but is limited by solvent interference. This study presents a liquid-liquid microextraction (LLME)-assisted HPLC-FTIR method for isolating and identifying bioactive compounds in complex supplement matrices. HPLC fractions of a branched-chain amino acid beverage were subjected to LLME using infrared-transparent, non-polar solvents to remove mobile phase residues and buffer salts prior to FTIR analysis. Extraction parameters, solvent composition, and buffer effects were optimized and compared with conventional solvent evaporation. The LLME approach effectively eliminated solvent and salt interference, yielding clear spectra that enabled identification of citric acid, L-ascorbic acid, valine, leucine, isoleucine, and caffeine. The method uses standard laboratory equipment and is compatible with common chromatographic systems, offering a practical solution for routine supplement quality control and regulatory testing. This LLME-assisted HPLC-FTIR strategy provides a reliable pathway for infrared-based identification of active ingredients in complex food and pharmaceutical products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.